Insider Trading & Ownership - DEPOMED INC (DEPO)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for DEPOMED INC
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2020-05-08
Sale		2020-05-11
8:23 pm		Assertio Therapeutics IncASRTDAWES KAREN A
Director		15,834$0.7914$12,53184,589
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2020-04-02
Exercise(A)		2020-04-03
7:54 pm		N/A
2021-04-02		Assertio Therapeutics IncASRTBukofzer Stan
SVP, Chf Scitfc & Tech Officer		25,370$0103,500
(Direct)		View
2020-04-02
Tax Withholding(A)		2020-04-03
7:54 pm		N/A
N/A		Assertio Therapeutics IncASRTBukofzer Stan
SVP, Chf Scitfc & Tech Officer		7,433$0.6467103,500
(Direct)		View
2020-04-02
Exercise		2020-04-03
6:50 pm		N/A
2021-04-02		Assertio Therapeutics IncASRTBukofzer Stan
SVP, Chf Scitfc & Tech Officer		25,370$0103,500
(Direct)		View
2020-04-02
Tax Withholding		2020-04-03
6:50 pm		N/A
N/A		Assertio Therapeutics IncASRTBukofzer Stan
SVP, Chf Scitfc & Tech Officer		7,433$0103,500
(Direct)		View
2020-03-30
Exercise		2020-03-31
7:32 pm		N/A
2022-03-30		Assertio Therapeutics IncASRTGaleota James JR
Director		12,492$037,475
(Direct)		View
2020-02-18
Exercise		2020-02-19
5:00 pm		N/A
2022-02-18		Assertio Therapeutics IncASRTMason Heather L
Director		14,394$043,182
(Direct)		View
2020-02-12
Exercise		2020-02-12
6:41 pm		N/A
2022-02-12		Assertio Therapeutics IncASRTPeisert Daniel A.
SVP and CFO		27,588$0158,383
(Direct)		View
2020-02-12
Tax Withholding		2020-02-12
6:41 pm		N/A
N/A		Assertio Therapeutics IncASRTPeisert Daniel A.
SVP and CFO		9,545$1.35158,383
(Direct)		View
2020-02-12
Exercise		2020-02-12
6:41 pm		N/A
2022-02-12		Assertio Therapeutics IncASRTHIGGINS ARTHUR J
Director, President and CEO		97,412$0617,564
(Direct)		View
2020-02-12
Tax Withholding		2020-02-12
6:41 pm		N/A
N/A		Assertio Therapeutics IncASRTHIGGINS ARTHUR J
Director, President and CEO		31,008$1.35617,564
(Direct)		View
2020-02-12
Exercise		2020-02-12
6:40 pm		N/A
2022-02-12		Assertio Therapeutics IncASRTBukofzer Stan
SVP, Chf Scitfc & Tech Officer		27,588$0100,154
(Direct)		View
2020-02-12
Tax Withholding		2020-02-12
6:40 pm		N/A
N/A		Assertio Therapeutics IncASRTBukofzer Stan
SVP, Chf Scitfc & Tech Officer		9,545$1.35100,154
(Direct)		View
2020-02-06
Exercise		2020-02-06
5:49 pm		N/A
2021-02-06		Assertio Therapeutics IncASRTPeisert Daniel A.
SVP and CFO		6,700$0463,487
(Direct)		View
2020-02-06
Tax Withholding		2020-02-06
5:49 pm		N/A
N/A		Assertio Therapeutics IncASRTPeisert Daniel A.
SVP and CFO		2,318$1.04463,487
(Direct)		View
2020-02-04
Option Award		2020-02-06
5:49 pm		N/A
2023-02-04		Assertio Therapeutics IncASRTPeisert Daniel A.
SVP and CFO		371,622$0463,487
(Direct)		View
2020-02-06
Exercise		2020-02-06
5:49 pm		N/A
2021-02-06		Assertio Therapeutics IncASRTHIGGINS ARTHUR J
Director, President and CEO		62,399$01,456,574
(Direct)		View
2020-02-06
Tax Withholding		2020-02-06
5:49 pm		N/A
N/A		Assertio Therapeutics IncASRTHIGGINS ARTHUR J
Director, President and CEO		21,590$1.041,456,574
(Direct)		View
2020-02-04
Option Award		2020-02-06
5:49 pm		N/A
2023-02-04		Assertio Therapeutics IncASRTHIGGINS ARTHUR J
Director, President and CEO		1,037,838$01,456,574
(Direct)		View
2020-02-04
Option Award		2020-02-06
5:48 pm		N/A
2023-02-04		Assertio Therapeutics IncASRTBukofzer Stan
SVP, Chf Scitfc & Tech Officer		326,577$0326,577
(Direct)		View
(A) Indicate amendment filing.